Union Savings Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$541K Sell
9,389
-161
-2% -$9.24K 0.22% 76
2026
Q1
$579K Sell
9,550
-172
-2% -$10K 0.25% 70
2025
Q4
$524K Buy
+9,722
New +$468K 0.23% 79
2025
Q2
$424K Sell
9,797
-340
-3% -$16.7K 0.19% 86
2025
Q1
$618K Buy
10,137
+40
+0.4% +$2.33K 0.3% 61
2024
Q4
$571K Sell
10,097
-150
-1% -$8.38K 0.28% 66
2024
Q3
$530K Sell
10,247
-220
-2% -$10.3K 0.26% 71
2024
Q2
$435K Sell
10,467
-2,718
-21% -$122K 0.23% 86
2024
Q1
$715K Buy
13,185
+150
+1% +$7.64K 0.37% 63
2023
Q4
$669K Buy
13,035
+167
+1% +$8.77K 0.38% 65
2023
Q3
$747K Hold
12,868
0.47% 57
2023
Q2
$800K Buy
+12,868
New +$863K 0.48% 55

Other funds holding BMY

Union Savings Bank's BMY Position: Q2 2026 in Review

Union Savings Bank reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, selling an estimated $9.24K and leaving 9,389 shares worth $541K. The position accounts for 0.22% of the portfolio, ranked #76.

Union Savings Bank first reported a position in BMY in Q2 2023 and has held it in 12 quarters since. The position peaked at $800K in Q2 2023. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Union Savings Bank held 9,389 shares of Bristol-Myers Squibb worth $541K as of Q2 2026.
  • Union Savings Bank sold 161 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.24K.
  • Bristol-Myers Squibb made up 0.22% of Union Savings Bank's portfolio in Q2 2026, its #76 holding.
  • Union Savings Bank first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 12 quarters since.
  • Union Savings Bank's Bristol-Myers Squibb position peaked at $800K in Q2 2023.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Union Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.